GSK1292263 matching placebo
Sponsors
GlaxoSmithKline
Conditions
Diabetes Mellitus, Type 2
Phase 2
A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
CompletedNCT01119846
Start: 2009-06-05End: 2010-03-19Updated: 2018-01-17
A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
CompletedNCT01128621
Start: 2009-11-23End: 2010-04-12Updated: 2017-10-16